2025-05-29 - Analysis Report
Okay, here's a report summarizing the provided data for Hims & Hers Health Inc (HIMS), along with an analysis.

**Report on Hims & Hers Health Inc (HIMS)**

**0. Overview:**

*   **Ticker:** HIMS
*   **Company:** Hims & Hers Health Inc
*   **Description:** Hims & Hers Health Inc. operates as a telehealth company, offering a variety of health and wellness products and services online.

**1. Performance vs. S&P 500 (VOO):**

*   **HIMS Cumulative Return:** 266.45%
*   **VOO Cumulative Return:** 50.47%
*   **Absolute Divergence (Current):** 216.0
*   **Divergence Range:** (Max: 292.1, Min: -94.0)
*   **Relative Divergence:** 80.3

**Analysis of Alpha, Beta, CAGR, MDD**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2019-2021  | -46.0% | 51.0% | -90.0% | -0.0 | 1.5 |
| 2020-2022  | -15.0% | 72.1% | -21.0% | -0.0 | 1.4 |
| 2021-2023  | -51.0% | 72.1% | -68.0% | -0.1 | 2.0 |
| 2022-2024  | 127.0% | 78.4% | 110.0% | -0.2 | 5.4 |
| 2023-2025  | 261.0% | 78.4% | 232.0% | -0.1 | 11.9 |

**Analysis:**

*   **Cumulative Returns:** HIMS has significantly outperformed the S&P 500 (VOO) over the observed period. The current divergence is substantial, placing HIMS in the upper range of its historical divergence from the S&P 500.
*   **Alpha and Beta:**  The negative Beta values across the periods suggest that HIMS's returns are generally inversely correlated with the market (S&P 500). A positive Alpha indicates the stock has performed better than expected for the risk taken, with particularly strong Alpha in the 2022-2024 and 2023-2025 periods.
*   **CAGR and MDD:** The company showed high growth between 2023 and 2025, with a CAGR of 261.0%. However, Maximum Drawdown (MDD) also increased to 78.4% during this period, indicating higher volatility and risk.
*   **Capitalization:**  Market capitalization has grown significantly, especially in recent years, indicating increasing investor confidence and growth in the company’s market presence.

**2. Recent Price Action:**

*   **Current Price:** 53.34
*   **Previous Close:** 53.36
*   **Price Change:** -0.04
*   **5-day Moving Average:** 54.61
*   **20-day Moving Average:** 52.87
*   **60-day Moving Average:** 38.44

**Analysis:**

*   The current price is slightly down from the previous close. The 5-day moving average is above the 20-day moving average, which is above the 60-day moving average.  This *generally* suggests an upward trend, but the recent small price decrease warrants attention.

**3. Technical Indicators & Market Risk:**

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 51.27
*   **PPO:** -2.89
*   **Hybrid Signal:** cash_70%_Sell 0.6% of holdings (9 shares - Caution - MRI:0.37)
*   **Recent (20-day) Relative Divergence Change:** -13.7 (Negative - Indicates short-term decline)
*   **Expected Return (%):** -10.7% (Long-term relative to S&P 500)

**Analysis:**

*   The Market Risk Indicator (MRI) suggests low market risk.
*   The RSI is near the neutral level, indicating neither overbought nor oversold conditions.
*   The negative PPO suggests the short-term moving average is below the long-term moving average, indicating a potential downtrend.
*   The hybrid signal suggests selling a small portion of holdings (0.6%) and holding a high cash position (70%), indicating a cautious approach.
*   The negative change in relative divergence (-13.7) supports the cautious outlook, as it shows a short-term underperformance compared to the S&P 500.
*   The negative expected return (-10.7%) indicates that, based on current metrics, long-term investment may underperform the S&P 500.

**4. Recent News & Significant Events:**

*   **[2025-05-25]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-28]:** Analyst discussions about recent performance, industry trends, and global economic factors.
*   **[2025-05-26]:** Notable stock volatility due to news, earnings reports, or executive actions.
*   **[2025-05-27]:** Market experts highlighting both risks and opportunities.

**Analysis:**

*   Recent news suggests volatility and significant events affecting HIMS, making it crucial to stay informed about the latest updates.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-05-05 | 0.22 | 0.59 B$     |
| 2024-11-04 | 0.35 | 0.40 B$     |
| 2024-08-05 | 0.06 | 0.32 B$     |
| 2024-05-06 | 0.05 | 0.28 B$     |
| 2025-05-05 | 0.05 | 0.28 B$     |

**Analysis:**

*   EPS (Earnings Per Share) has fluctuated significantly, with recent data showing a positive trend. Revenue has consistently grown over the past year.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $0.59B   | 73.50%        |
| 2024-12-31 | $0.48B   | 76.81%        |
| 2024-09-30 | $0.40B   | 79.16%        |
| 2024-06-30 | $0.32B   | 81.30%        |
| 2024-03-31 | $0.28B   | 82.36%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE   |
|------------|----------|-------|
| 2025-03-31 | $0.55B   | 9.01% |
| 2024-12-31 | $0.48B   | 5.46% |
| 2024-09-30 | $0.44B   | 17.18%|
| 2024-06-30 | $0.36B   | 3.67% |
| 2024-03-31 | $0.34B   | 3.23% |

**Analysis:**

*   Revenue is growing consistently, indicating increasing sales and market presence. Profit margins, however, have slightly decreased in the most recent quarter.
*   Equity has increased steadily, but ROE (Return on Equity) has fluctuated, with a recent decline.

**7. Overall Summary:**

Hims & Hers Health Inc. (HIMS) has demonstrated strong historical outperformance relative to the S&P 500, but recent indicators suggest a more cautious outlook. While revenue continues to grow, profit margins and ROE have shown some recent weakness. Technical indicators also point towards a potential short-term downtrend and a longer-term underperformance relative to the market. The recent news highlights significant events and volatility, suggesting that investors should closely monitor developments and exercise caution. The hybrid signal recommends a high cash position and slight reduction in holdings. While past performance has been strong, the current environment warrants a more conservative approach to HIMS.
